Literature DB >> 14993246

ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.

Daisy Sahoo1, Timothy C Trischuk, Teddy Chan, Victor A B Drover, Samuel Ho, Giovanna Chimini, Luis B Agellon, Ricky Agnihotri, Gordon A Francis, Richard Lehner.   

Abstract

High levels of expression of the ATP binding cassette transporter A1 (ABCA1) in the liver and the need to over- or underexpress hepatic ABCA1 to impact plasma HDL levels in mice suggest a major role of the liver in HDL formation and in determining circulating HDL levels. Cultured murine hepatocytes were used to examine the role of hepatic ABCA1 in mediating the lipidation of apolipoprotein A-I (apoA-I) for HDL particle formation. Exogenous apoA-I stimulated cholesterol efflux to the medium from wild-type hepatocytes, but not from ABCA1-deficient (abca1(-/-)) hepatocytes. ApoA-I induced the formation of new HDL particles and enhanced the lipidation of endogenously secreted murine apoA-I in ABCA1-expressing but not abca1(-/-) hepatocytes. ABCA1-dependent cholesterol mobilization to apoA-I increased new cholesterol synthesis, indicating depletion of the regulatory pool of hepatocyte cholesterol during HDL formation. Secretion of triacylglycerol and apoB was decreased following apoA-I incubation with ABCA1-expressing but not abca1(-/-) hepatocytes. These results support a major role for hepatocyte ABCA1 in generating a critical pool of HDL precursor particles that enhance further HDL generation and passive cholesterol mobilization in the periphery. The results also suggest that diversion of hepatocyte cholesterol into the "reverse" cholesterol transport pathway diminishes cholesterol availability for apoB-containing lipoprotein secretion by the liver.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993246     DOI: 10.1194/jlr.M300529-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

Review 1.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

2.  Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease.

Authors:  Kristin L Bowden; Nicolas J Bilbey; Leanne M Bilawchuk; Emmanuel Boadu; Rohini Sidhu; Daniel S Ory; Hong Du; Teddy Chan; Gordon A Francis
Journal:  J Biol Chem       Date:  2011-07-10       Impact factor: 5.157

3.  Nuclear receptor DHR96 acts as a sentinel for low cholesterol concentrations in Drosophila melanogaster.

Authors:  Mattéa Bujold; Akila Gopalakrishnan; Emma Nally; Kirst King-Jones
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

4.  Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

Authors:  Frances M Platt; Christopher Wassif; Alexandria Colaco; Andrea Dardis; Emyr Lloyd-Evans; Bruno Bembi; Forbes D Porter
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

5.  Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation.

Authors:  Jihong Lian; Russell Watts; Ariel D Quiroga; Megan R Beggs; R Todd Alexander; Richard Lehner
Journal:  J Lipid Res       Date:  2019-02-08       Impact factor: 5.922

6.  A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion.

Authors:  Soonkyu Chung; Abraham K Gebre; Jeongmin Seo; Gregory S Shelness; John S Parks
Journal:  J Lipid Res       Date:  2010-04       Impact factor: 5.922

7.  Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-08       Impact factor: 4.698

8.  Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.

Authors:  Alexander C Bashore; Mingxia Liu; Chia-Chi C Key; Elena Boudyguina; Xianfeng Wang; Caitlin M Carroll; Janet K Sawyer; Adam E Mullick; Richard G Lee; Shannon L Macauley; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06-06       Impact factor: 8.311

9.  Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI.

Authors:  Ailing Ji; Joanne M Wroblewski; Lei Cai; Maria C de Beer; Nancy R Webb; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2011-12-20       Impact factor: 5.922

Review 10.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.